-
Mashup Score: 5Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study - 4 day(s) ago
Background Microscopic colitis (MC) is an inflammatory disorder of the colon. To date, the relationship between inflammatory eye diseases and MC is unclear. Objective To assess whether inflammator…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The OncoAlert Newsletter - 7 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 17The OncoAlert Newsletter - 7 day(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet-
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM
-
-
Mashup Score: 14
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Our Highlighted Article of the Week in Video Format 🚨 "Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer" by @BiagioRicciutMD 🇺🇸 #NSCLC #LungCancer 🫁 Link Direct to Paper: https://t.co/jD4zUoVusC https://t.co/fqfOk2aM1B
-
-
Mashup Score: 5How Sound Are High-intensity Focused Ultrasound Data? - 9 day(s) ago
A diagnosis of prostate cancer (PC) is a life-changing event that often prompts asymptomatic men to opt for local treatment. The cancer control afforded by conventional treatments such as radical prostatectomy (RP) and radiotherapy is high [1] but is associated with toxicity, impacting quality of life in men with often long life expectancy [2]. Side effects widely vary for different whole-gland treatment options, including RP and radiotherapy. These toxicities rather than the lack of efficacy of more conventional treatment options have boosted the use of focal treatment (FT) options.
Source: www.europeanurology.comCategories: General Medicine News, Hem/OncsTweet-
RT @bavilima: How Sound Are High-intensity Focused Ultrasound Data? - European Urology https://t.co/FJVpyMdwjO Focal therapy shows promise…
-
-
Mashup Score: 12ESTRO/EANO recommendation on reirradiation of glioblastoma - 10 day(s) ago
Reirradiation of brain tumors has a long history of preclinical and clinical studies especially with regards to effectiveness and safety in the recurrent setting. Clinical benefit for reirradiation of brain tumors with data from individual case series dates back more than 80 years [61]. In a recent systematic review by the European Society of Radiotherapy and Oncology (ESTRO) and the European Organization for Research and Treatment of Cancer (EORTC) of 439 studies conducted from 2000 to 2020 on reirradiation, 117 (24 %) involved the brain, and most of them included patients with high-grade gliomas [2].
Source: www.thegreenjournal.comCategories: General Medicine News, Hem/OncsTweet-
RT @to_be_elizabeth: 📌 ESTRO/EANO recommendation on reirradiation of glioblastoma 🧠 https://t.co/7nfnAI6Zlt 👉🏻Reirradiation for GB should…
-
-
Mashup Score: 2Adnexal lesions: Preoperative assessment - 25 day(s) ago
The ENYGO Podcast · Episode
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
RT @ArturasDobilas: Thanks👏 @OncoAlert @nsgo_org @ESGO_society https://t.co/qqW9TgyjOx
-
-
Mashup Score: 8Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer - 1 month(s) ago
This cohort study assesses the feasibility and safety of a community-based magnetic resonance imaging (MRI) diagnostic strategy in men with suspected prostate cancer using 3-year active monitoring.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
RT @APCCC_Lugano: Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected #ProstateCancer https://t.co/CDA1GgILQT…
-
-
Mashup Score: 3
Bora Lim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the Phase II LITESPARK-029 trial (NCT06428396) of belzutifan, a HIF-2α inhibitor, with fulvestrant versus everolimus with fulvestrant or exemestane in patients with ER+/HER2- unresectable or metastatic breast cancer. Primary endpoints include progression-free survival (PFS) and secondary objectives include overall survival and clinical benefit. This trial aims to address resistance mechanisms and improve outcomes in advanced disease. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjoncology.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoAlert: LITESPARK-029 Report with Bora Lim ( @VJOncology) https://t.co/fM553nrRp7 evaluating the efficacy of belzutifan, a HIF-2α…
-
-
Mashup Score: 7Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome - 1 month(s) ago
Background Pathogenic germline variants in the mismatch repair (MMR) genes are associated with an increased risk of prostate cancer (PCa). Since 2010 we have recommended MMR carriers annual PSA test…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
RT @APCCC_Lugano: Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome https://t.co/ER6PUY42Kt…
-
RT @LumirKunovsky: 📕 Read the articles exclusively in @UEGJournal 👑 1️⃣👉https://t.co/NwcuGOEdqC 2️⃣👉https://t.co/VoGjx1nHPy 3️⃣👉https://t.…